Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Attenborough Medical from Lokeren, company number BE0794989531, closed financial year 2025 with a result of € -24,702 after tax. For that financial year Attenborough Medical recorded a gross margin of € 38,020 and equity of € -54,355. Compared with financial year 2024, the result moved from € -29,976 to € -24,702. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.
€ -54,355
▼ € 24,702 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -24,702
▲ 18 % less loss than in 2024
Profit after tax over the fiscal year.
€ 11
▼ € 40,836 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -64,355.
People and assets in 2025
1
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 51,456
▼ 43% vs 2024
€ 51,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 36,321
▼ 40% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,022
▲ € 9,012 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 5,529 | € 64,315 | € 38,020 | ▼ 41% |
| Profit after taxes | € -9,677 | € -29,976 | € -24,702 | ▲ € 5,275 |
| Equity | € 323 | € -29,653 | € -54,355 | ▼ € 24,702 |
| Total debts | € 29,164 | € 202,759 | € 187,273 | ▼ 8% |
| Cash | € 1,528 | € 40,848 | € 11 | ▼ € 40,836 |
| Retained profit | € -9,677 | € -39,653 | € -64,355 | ▼ € 24,702 |
| Balance sheet total | € 29,487 | € 173,106 | € 132,918 | ▼ 23% |
| Employees (FTE) | - | 1.3 | 1 | ▼ 0.3 |
Key figures of Attenborough Medical, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 November 2026.
What happened to Attenborough Medical?
What happened at Attenborough Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 24,702. filed late Source: NBB ↗
- New establishment in Lokeren. KBO
- Chee AW became a director. NBB
- Edward Attenborough became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 9,677 loss in 2023 to € 24,702 loss in 2025.
Paid € 75 in corporate taxes since 2023.
On average € 38,000 of value added per employee in 2025.
A new publication or filing at Attenborough Medical? We notify you, reason included.
Follow Attenborough MedicalDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Attenborough Medical are Chee AW and Edward Attenborough.
Directors
According to the 2025 annual accounts
Chee AW
Director
since 2022
Edward Attenborough
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Mosten 13
9160 Lokeren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →RSI Sports Panels
€ 290,053 gross margin · 2025
OnCourt EU
€ 39,540 gross margin · 2025
ProCenTis
GROUP PENNEMAN
ENGIPLAST
€ 1.4 million gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
implantify.eu
Registrar
Combell NV
Website info
Features
Security
Details
- Company number
- 0794.989.531
- VAT number
- BE 0794.989.531
- Registered office
- Mosten 13, 9160 Lokeren
- Names & denominations
- Attenborough Medical
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 2022
- Peppol
- Active · Active since 13 Jan 2026
- Contact
- implantify.eu
- Activities · NACE
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Activiteiten van tandartspraktijken